LEN — Lennar Corporation

The market is clearly sour on LEN. Q3 FY26 EPS fell to $1.19 from $2.29 a year earlier, home-sales gross margin compressed to 15.8% from 17.5%, SG&A rose to 9.2% of home sales revenue, new orders dropped 9% YoY and deliveries fell 3%, and management trimmed FY26 delivery guidance. BofA, Wells Fargo and Truist all cut price targets around the print. The stock sits just above its 52-week low ($76.63 vs. a high of $134.07), is -6.1% vs. its 20-day SMA and -19.1% vs. its 200-day SMA, and RSI at 37.22 shows persistent selling without capitulation.

This is a multi-quarter structural down-cycle in profitability, not a one-quarter blip. Diluted EPS has fallen in a near-straight line: $4.82 (Q4 FY23) → $4.06 (Q4 FY24) → $2.29 (Q3 FY25) → $0.94 (Q1 FY26) → $1.23 (Q2 FY26) → $1.19 (Q3 FY26), i.e. down ~48% YoY in the latest quarter and ~63% below the FY2024 peak (~$14.34 annualized). Revenue is following: Q3 FY26 revenue of $8.05B was down 8.7% YoY and well below the $10.97B posted in Q4 FY23. Margins are the core problem — home-sales gross margin of 15.8% vs. 17.5% a year ago with SG&A rising — as price incentives and weak demand squeeze profitability. The trend is decelerating across every line; the debate is whether this is a cyclical trough (rates-driven) or a durable reset, and nothing in the trailing data yet shows a bottom.

Mixed, and the mix is instructive. On trailing earnings LEN looks expensive versus itself: P/E TTM of 14.81 vs. a 5-year average of 10.15, because earnings are depressed (PEG of -0.31 is meaningless with negative growth). But on sales and book it looks cheap: P/S of 0.609 vs. a 5-year average of 1.06, and P/B of 0.864 (below book value). Forward P/E on next-FY consensus EPS of $5.462 is ~14.3x at $78.36. The dividend yield of 2.37% is also elevated versus its own history — a function of the price decline, not a payout increase. Net: the stock is not cheap on depressed earnings, but it is cheap on revenue and below book, which is the classic signature of a cyclical trough where the multiple normalizes as earnings recover.

The market is pricing in continued deterioration: price near 52-week lows, below all major moving averages, targets cut. Yet at 0.86x book and 0.61x sales, a lot of bad news is already discounted. The key question is whether earnings have bottomed. If mortgage rates ease and affordability improves, LEN's trough EPS (~$5.5) could re-rate toward mid-cycle ($7-9+), which would make today's price look cheap; if demand stays weak and incentives persist, earnings can fall further and the 'cheap' book value could erode via land impairments. This is a trough-timing bet on rates, not a growth story.

As of 2026-09-17, LEN is in a clean downtrend. RSI(14) stood at 37.22 — weak, but not yet oversold (no <30 capitulation signal), leaving room to fall. Price was -6.14% vs. the 20-day SMA, -7.12% vs. the 50-day SMA and -19.11% vs. the 200-day SMA, with -6mo returns of -17.3%. The stock is sitting just above its 52-week low of $76.63. There is no base or reversal signal; entry-timing discipline argues for waiting for RSI near/below 30 or a confirmed stabilization above the 20-day SMA before treating this as a bottom.

• 30-year fixed mortgage rates hovering near 6.8% on sticky above-target inflation, directly crushing purchase affordability and buyer traffic.
• Affordability wall: home prices ~21% above historical norms, squeezing entry-level buyers — Lennar's core demographic — and pushing would-be buyers into rentals.
• Federal Reserve policy path: any pivot toward rate cuts would be the single biggest swing factor for demand and for LEN's multiple.
• Housing/consumer-cyclical sector rotation out of favor, compounding multiple compression independent of company execution.
• Land-light model and construction efficiencies as partial offsets — controlled 488k homesites with <2.5% owned, construction costs per sq ft -6% YoY, and record-low 116-day cycle times.

• Q3 FY26 earnings call on September 17, 2026 (11:00 AM ET) — management commentary on demand elasticity and margin defense.
• Fall selling-season order/delivery metrics and whether the trimmed 80-81k delivery guide holds or needs another cut.
• Mortgage rate trajectory / Fed policy — a sustained move lower in rates would revive affordability and re-rate the stock.
• Continued capital return (3M shares repurchased for $256M in the quarter, $400M of notes redeemed) and any further portfolio/spin-off actions.

• Further gross-margin compression if pricing incentives and weak demand persist, with no clear floor yet visible.
• Additional guidance cuts if orders (already -9% YoY) keep falling through the fall selling season.
• Prolonged elevated mortgage rates extending the down-cycle and keeping buyers sidelined.
• Value-trap risk: below-book valuation is only protective if book value holds — land impairments could erode it.
• Cyclical earnings could fall further before recovering, making the trailing P/E of 14.8x look cheap in hindsight.

Lennar is a high-quality, low-leverage homebuilder (net homebuilding debt-to-cap of just 12.7%) trading below book value with trough-cycle earnings — genuinely interesting for a patient investor betting on a rate-driven recovery. But the down-cycle is not clearly over: orders are still falling, gross margin is still compressing, guidance was just cut, and the technicals show no bottom. This is a reasonable watchlist/accumulate-on-weakness name for someone willing to underwrite a multi-quarter recovery, not a clear 'buy now' — and not a structural short either, given the fortress balance sheet and below-book price.

Blend of two approaches: (1) ~15x next-FY consensus EPS of $5.462 = ~$82, a trough-earnings multiple set above the 5-year average P/E of 10.15 (which was earned on peak-cycle earnings, making it inappropriate to apply to depressed EPS); and (2) ~0.95x book value (~$87-90 BVPS) = ~$83-86, reflecting that LEN's low leverage and below-book trading support a discount-to-par book multiple. Averaging the two gives ~$84, modestly above the $78.36 price as of 2026-09-17.